Is Low-Carbohydrate Diet Safe and Effective for Type 2 Diabetes Remission in Long-Term? Dr. Bhumika Maikhuri24 Oct 2025 11:16 AM ISTA recent systematic review has found that low-carbohydrate diets (LCDs) and ketogenic diets (KDs) are effective and viable strategies for achieving...
FDA Approves Oral Semaglutide for Cardiovascular Risk Reduction in Type 2 Diabetes Dr. Kamal Kant Kohli23 Oct 2025 9:00 AM ISTThe FDA has approved oral semaglutide (Rybelsus) 7 mg and 14 mg tablets to lower the risk of cardiovascular death, heart attack, or stroke in...
Medical Bulletin 18/October/2025 Dr. Bhumika Maikhuri18 Oct 2025 3:00 PM ISTHere are the top medical news for the day:Can ADHD Make You More Creative by Letting Your Mind Wander? A new study presented at the European College...
Comparable Cardiorenal Outcomes Among Three GLP-1 Receptor Agonists in Veterans with Type 2 Diabetes: JAMA Medha Baranwal18 Oct 2025 9:00 AM ISTUSA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor agonists-semaglutide,...
Mediterranean Diet and Lifestyle Changes Cut Type 2 Diabetes Risk by 31 Percent: Study Finds Dr. Bhumika Maikhuri18 Oct 2025 8:30 AM ISTA large-scale Spanish clinical trial has found that simple lifestyle changes like eating a Mediterranean-style diet with fewer calories, engaging in...
GLP-1 Drugs Linked to Higher Depression Risk but Lower Mortality, suggests research Dr Riya Dave17 Oct 2025 9:30 AM ISTResearchers have identified that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are widely used to control type 2 diabetes and obesity,...
SGLT-2 diabetes drugs linked to lower risk of autoimmune diseases, suggests study Dr. Kamal Kant Kohli16 Oct 2025 11:15 AM ISTSodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic...
FDA Accepts sBLA for inhaled insulin for kids and adolescents Following Positive Phase 3 Results Dr. Kamal Kant Kohli15 Oct 2025 9:15 AM ISTThe FDA has accepted MannKind's supplemental biologics license application (sBLA) for Afrezza (insulin human inhalation powder) to treat children and...
EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress Deeksha Bhandari14 Oct 2025 12:51 PM ISTEvery 12 minutes, a person with diabetes thinks about their condition. For many, this constant burden leads to diabetes distress-a state of...
DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings Deeksha Bhandari13 Oct 2025 12:30 PM ISTDAa-ViNCI study which analyzed the efficacy, safety and practice of pattern of Vildagliptin 100mg and dapagliflozin 10mg in cardiology practice. ...
Medical Bulletin 11/October/2025 Dr. Bhumika Maikhuri11 Oct 2025 3:00 PM ISTThis Rare Gene Mutation May Be Linked to Diabetes in Babies Under Six MonthsA recent study published in the Journal of Clinical Investigation has...
How PM2.5 Pollutants Reprogram Brown Fat and Raise Diabetes Risk? Study Provides Insights Dr. Bhumika Maikhuri11 Oct 2025 8:15 AM ISTA new study published in JCI Insights has revealed that long-term exposure to fine air pollution may significantly impair metabolic health, providing...
